Total Syntheses of Mycobactin Analogues as Potent Antimycobacterial Agents Using a Minimal Protecting Group Strategy

Journal of Organic Chemistry

Volumn 63, Issue 13, 1998, Pages 4314-4322

  Xu, Yanping ^a   Miller, Marvin J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXY 7 AZABENZOTRIAZOLE; ANTIMYCOBACTERIAL AGENT; CYANAMIDE; FERRIC ION; FUNCTIONAL GROUP; MYCOBACTIN DERIVATIVE; SIDEROPHORE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; MYCOBACTERIUM; NONHUMAN;

EID: 0032569011     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo980063o     Document Type: Article

References (30)

1. Brown, D. U.S. Tuberculosis Cases Decline as Disease Increases Worldwide. The Washington Post, March 23, 1996.
2. Schatz, A.; Bugie, E.; Waksman, S. A. Proc. Soc. Exp. Biol. Med. 1944, 55, 66.
3. Lemke, T. L. In Principles of Medicinal Chemistry, 4th ed.; Foye, W. O., Lemke, T. L., Williams, D. A., Eds.; Williams & Wilkins: Baltimore, 1995; pp 747-758.
4. Lemonick, M. D. The Killer All Around. Time Magazine; Lemonick, M. D., Ed.; Time, Inc.: New York, Sept 12, 1994; p 62.
5. Facts and Figures: Tuberculosis Today, World Health Organization's 1995 report on tuberculosis.
6. (a) DiGiacomo, M. A Deadly Return. Newsweek, March 16, 1992, p 53.
7. (b) Tuberculosis and HIV Public Health Policy: A Dual Challenge-Washington: AIDS Action Foundation, March 1992.
8. (a) Connell, N. D.; Nikaido, H. Membrane Permeability and Transport in Mycobacterium Tuberculosis. In Tuberculosis: Pathogenesis, Protection, and Control; Bloom, B. R., Ed.; ASM Press: Washington, DC, 1994; p 333.
9. (b) Liu, J.; Rosneberg, E. Y.; Nikaido, H. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 11254.
10. (c) Besra, G. S.; Chatterjee, D. Lipid and Carbohydrates of Mycobacterium Tuberculosis. In Tuberculosis: Pathogenesis, Protection, and Control; Bloom, B. R., Ed.; ASM Press: Washington, DC, 1994; p 285.
11. (a) Neilands, J. B. In Microbial Iron Metabolism. A Comprehensive Treatise; Neilands, J. B., Ed.; Academic Press: New York, 1974; p 3.
12. (b) Emery, T. Met. Ions Biol. Syst. 1978, Chapter 3, 7.
13. (c) Emery, T. Biochemistry 1971, 10, 1483.
14. (a) Anderson, W. F. In Inorganic Chemistry in Biology and Medicine; Martell, E., Ed.; American Chemical Society: Washington, DC, 1980; Chapter 15.
15. (b) Weatherall, D. J. In Development of Iron Chelators for Clinical Use; Martell, A. E., Anderson, W. F., Badman, D. G., Eds.; Elsevier/North-Holland; New York, 1981; p 3.
16. (c) Waxman, H. S.; Brown, E. B. Prog. Hematol. 1969, 6, 338.
17. Snow, G. A. Bacteriol. Rev. 1970, 34, 99.
18. Carpenter, J. G.; Moore, J. W. J. Chem. Soc. C 1969, 12, 1610.
19. Maurer, P. J.; Miller, M. J. J. Am. Chem. Soc. 1983, 105, 240.
20. Hu, J.; Miller, M. J. J. Am. Chem. Soc. 1997, 119, 3462.
21. Hu, J. Ph.D. Dissertation. Total Synthesis of Mycobactins, Siderophore-Drug Conjugates, and Biological Studies. Department of Chemistry and Biochemistry, University of Notre Dame, 1996.
22. (a) Carpino, L. A. J. Am. Chem. Soc. 1993, 775, 4397.
23. (b) Carpino, L. A. J. Org. Chem. 1995, 60, 3561.
24. (c) Musiol, H.-J. J. Org. Chem. 1994, 59, 6144.
25. (d) Angell, Y. M. J. Am. Chem. Soc. 1995, 117, 7279.
26. (e) Carpino, L. A. Tetrahedron Lett. 1994, 35, 2279.
27. (f) Carpino L. A.; EI - Faham, A. J. Org. Chem. 1994, 59, 695.
28. (g) Carpino, L. A. J. Chem. Soc., Chem. Commun. 1994, 201.
29. Miller, M. J.; Mattingly, P. G.; Morrison, M. A.; Kerwin, J. F., Jr. J. Am. Chem. Soc. 1980, 102, 7026.
30. Arai H.; Hagmann, W. K.; Suguna, H.; Hecht, S. M. J. Am. Chem. Soc. 1980, 702, 6631.